FIELD: medicine.
SUBSTANCE: pharmaceutical composition can additionally contain ethylenediaminotetraacetic acid, polyvinyl pyrrolidone, polyvinyl alcohol, a preserving agent specified in a group: Nipagin, Nipasol, benzoic acid, sodium benzoate, sorbic acid, benzalkonium chloride. As a body-forming base, the composition can contain distilled water, polyethylene oxide 400, polyethylene oxide 4000, polyethylene glycol, propylene glycol, a phosphate buffer, a borate buffer, an acetate-borate buffer depending on a dosage form.
EFFECT: high therapeutic effectiveness, prolonged corneal contact of the preparation which reduces the number of instillations, avoids a risk of side effects and provides good tolerance.
5 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EYE DROPS | 2012 |
|
RU2504372C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF GEL FOR TREATING METABOLIC INVOLVEMENTS OF OCULAR TISSUES | 2014 |
|
RU2575558C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF EYE DROPS FOR PREVENTING AND TREATING ALLERGIC EYE DISEASES | 2013 |
|
RU2549472C1 |
| OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561048C1 |
| OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
| GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
| OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
| JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS | 2013 |
|
RU2533274C1 |
| EYE DROPS FOR DRY EYE SYNDROME | 2011 |
|
RU2459615C1 |
| EYE DROPS POSSESSING ANTIINFLAMMATORY AND ANTIBACTERIAL ACTION | 2012 |
|
RU2506086C1 |
